*** Apologies for cross-posting ***
AOM Symposium on "Scientists in the Corporate Research Environment" (session 112)
We cordially invite you to join us for a paper symposium focusing on a diverse set of issues related to scientists operating in the private sector. The symposium will take place in-person on August 5th 2022 from 10:30AM to 12:00PM (Seattle / Pacific Daylight Time).
The symposium features four papers that examine understudied theoretical questions and phenomena related to the role of scientists in driving innovation in the private sector. The four papers use diverse theoretical frameworks, methodologies, levels of analysis, and empirical contexts to address an interesting set of questions. In particular, they investigate the influence of corporate board directors with a scientific background on firm innovation, the role of open science policies on scientist hiring in firms, and the impact of national intellectual property rights institutions on the direction of scientists' research and their mobility at the international level. Together, they yield insights on how technology firms may leverage the particularities of their research environment to attract high quality scientific human capital and improve their innovative performance, thereby contributing to the establishment of their competitive advantage.
Papers
Independent Board and Firm Innovation: Does Director Background Matter?
Waverly W. Ding, University of Maryland
Fenmian Wang, University of International Business and Economics
Hong Zhang, Wuhan University
Shi Chen, Southwestern University of Finance and Economics
The Big Reveal: Human Capital Shortage and Firm-level Publications Strategy in Artificial Intelligence Research
Nur Ahmed, Massachusetts Institute of Technology
How TRIPS Implementation Influenced the Exportation of Science from Low- and Middle-Income Countries
Michael Blomfield, University of Massachusetts Amherst
Anita M. McGahan, University of Toronto
Keyvan Vakili, London Business School
Intellectual Property Rights Institutions and Cross-Border Scientist Mobility: Evidence from Pharmaco-Genetics
Martin Hetu, University of Toronto
Denisa Mindruta, HEC Paris
Will Mitchell, University of Toronto
Discussion
Matt Marx, Cornell University
Please feel free to reach out to Nur Ahmed (nurahmed@mit.edu) or Martin Hetu (martin.hetu@rotman.utoronto.ca) if you have any questions.
------------------------------
Martin Hetu
Post Doctorate Fellow
Rotman School of Management, University of Toronto
Toronto ON
------------------------------